An open trial of zimelidine in patients with endogenous depression.

Abstract	13 patients with endogenous depression, who had failed to obtain a lasting response to other antidepressant drugs or to electroconvulsive therapy, were treated with zimelidine. 3 showed a marked, and 3 a mild improvement. Side effects were minimal.
Authors	L G Kiloh, G Moore
Journal	International pharmacopsychiatry (Int Pharmacopsychiatry) Vol. 17 Issue 1 Pg. 28-35 ( 1982) ISSN: 0020-8272 [Print] Switzerland
PMID	6211416 (Publication Type: Clinical Trial, Journal Article)
Chemical References	Antidepressive Agents Pyridines Zimeldine Brompheniramine
Topics	Aged Antidepressive Agents (adverse effects, therapeutic use) Brompheniramine (adverse effects, analogs & derivatives, therapeutic use) Clinical Trials as Topic Depressive Disorder (drug therapy, psychology) Female Headache (chemically induced) Humans Male Middle Aged Personality Inventory Pyridines (therapeutic use) Zimeldine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!